文献速递结核与非结核分枝杆菌艾滋病与性传播感染

FujiLAM脑脊液检测成人HIV合并结核性脑膜炎

Fujifilm SILVAMP TB LAM Assay on Cerebrospinal Fluid for the Detection of Tuberculous Meningitis in Adults With Human Immunodeficiency Virus.
PubMed 文献 · Clin Infect Dis · 2021-01-01

在乌干达开展的前瞻性队列研究纳入101例疑似结核性脑膜炎患者(95例HIV阳性),评估脑脊液FujiLAM检测性能。FujiLAM对确定或很可能结核性脑膜炎的敏感性为52%(30/58),Xpert Ultra为55%(32/58),FujiLAM特异性98%(42/43);在同时检测亚组中FujiLAM敏感性高于AlereLAM(50% vs 14%,P<.01)。

要点

  • 脑脊液FujiLAM敏感性52%,接近Xpert Ultra的55%。
  • FujiLAM特异性98%,在无确定/很可能结核性脑膜炎患者中。
  • 同时检测亚组中FujiLAM敏感性高于AlereLAM(50% vs 14%)。

核心结论

  • FujiLAM脑脊液检测敏感性高于AlereLAM,可能接近Xpert Ultra,或可改善治疗启动时间。

研究设计与样本

  • 在乌干达Kiruddu国家转诊医院开展的前瞻性队列研究,纳入101例疑似结核性脑膜炎患者,其中95例HIV阳性。

主要发现

  • 101例中34例为确定结核性脑膜炎,24例为很可能结核性脑膜炎。
  • FujiLAM对确定或很可能结核性脑膜炎的敏感性为52%(30/58),Xpert Ultra为55%(32/58)。
  • 在同时接受FujiLAM和AlereLAM检测的亚组中,FujiLAM敏感性50%(14/28),AlereLAM为14%(4/28),P<.01。
  • FujiLAM在无很可能或确定结核性脑膜炎患者中的特异性为98%(42/43)。

临床怎么用

  • FujiLAM可用于脑脊液检测辅助诊断成人HIV合并结核性脑膜炎,尤其在Xpert Ultra系统不可行时。

局限性

  • 需要大规模验证性研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tuberculous meningitis (TBM) has a high fatality rate, with inadequate diagnostic tests being a major contributor. The rollout of Xpert MTB/Rif and Xpert MTB/RIF Ultra (Xpert Ultra) have improved time-to-diagnosis with sensitivities similar to culture, yet test availability and sensitivity are inadequate. The TB lipoarabinomannan lateral flow assay (AlereLAM) offers ease of use, but its low sensitivity in cerebrospinal fluid (CSF) limits clinical utility for TBM. The Fujifilm SILVAMP TB LAM (FujiLAM) assay has excellent sensitivity in urine, but performance on cerebrospinal fluid is uncertain. METHODS: We conducted a prospective cohort study at Kiruddu National Referral Hospital in Kampala, Uganda, enrolling patients suspected to have TBM. CSF was tested using AlereLAM, Xpert Ultra, culture, and FujiLAM. Results were compared with 2 reference standards: probable and definite TBM or definite TBM alone by the uniform TBM case definition. RESULTS: Of 101 patients enrolled (95/101 HIV-positive), 34 had definite TBM and 24 had probable TBM. FujiLAM sensitivity on CSF was 52% (30/58) for definite or probable TBM compared with 55% (32/58) for Xpert Ultra. AlereLAM had lower sensitivity than FujiLAM in the subgroup of patients tested with both assays (14% [4/28] vs 50% [14/28]; P < .01). FujiLAM specificity was 98% (42/43) for patients without probable or definite TBM. CONCLUSIONS: FujiLAM showed higher sensitivity than AlereLAM, with sensitivity potentially approaching that of Xpert Ultra. FujiLAM could improve time-to-treatment-initiation, especially in settings where the more technical Xpert Ultra system might not be feasible. Large confirmatory studies are needed.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Quinn CM, Kagimu E, Okirworth M, et al. Fujifilm SILVAMP TB LAM Assay on Cerebrospinal Fluid for the Detection of Tuberculous Meningitis in Adults With Human Immunodeficiency Virus. Clin Infect Dis. 2021. PMID: 33388751. doi:10.1093/cid/ciaa1910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。